Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alcoholic Fibrosis of Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01937130
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of IDN-6556 in ACLF

Who this might be right for
Acute on Chronic Hepatic FailureAcute Liver FailureLiver Cirrhosis+1 more
Conatus Pharmaceuticals Inc. 23
Not applicableLooking for participantsNCT06308757
What this trial is testing

Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis

Who this might be right for
NASHNAFLDObesity+1 more
University of Bologna 42
Post-approval studies (Phase 4)Looking for participantsNCT05644717
What this trial is testing

Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD

Who this might be right for
Liver FatLiver FibrosisGlycemic Control+3 more
Getz Pharma 164
Not applicableStudy completedNCT03608748
What this trial is testing

Early Detection of Advanced Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver DiseaseLiver Fibrosis
HaEmek Medical Center, Israel 1,000
Not applicableStudy completedNCT03198104
What this trial is testing

Assessing Kids for Liver Inflammation and Fibrosis Using Non-invasive MRI

Who this might be right for
Non-alcoholic SteatohepatitisLiver DiseasesLiver Fibroses+2 more
Perspectum 35
Not applicableUnknownNCT04369521
What this trial is testing

Evaluation of the Effects of a Low Free Sugar Diet in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver Disease
National Nutrition and Food Technology Institute 50
Not applicableStudy completedNCT01122797
What this trial is testing

Influence of Adiponutrin in Chronic Liver Disease

Who this might be right for
Alcoholic Liver Disease
Erasme University Hospital 658
Post-approval studies (Phase 4)UnknownNCT00239096
What this trial is testing

Prevention of Decompensation in Liver Cirrhosis

Who this might be right for
Alcoholic Liver CirrhosisAscites
Odense University Hospital 100
Not applicableActive Not RecruitingNCT06315361
What this trial is testing

DIAbetes and NAFLD

Who this might be right for
NAFLDDiabetesNASH+3 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 600
Testing effectiveness (Phase 2)Study completedNCT03486899
What this trial is testing

Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis

Who this might be right for
Liver FibrosisNonalcoholic Fatty Liver Disease (NAFLD)Nonalcoholic Steatohepatitis
Bristol-Myers Squibb 197
Not applicableWithdrawnNCT03980912
What this trial is testing

Validation of the LiverFASt Test and the Associated Fibrosis Staging Scores Compared to Liver Tissue Pathology Via Liver Biopsy

Who this might be right for
NAFLDNASH
Fibronostics USA, Inc
Testing effectiveness (Phase 2)Study completedNCT04771273
What this trial is testing

Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3)

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Boehringer Ingelheim 295
Testing effectiveness (Phase 2)Study completedNCT03008070
What this trial is testing

Phase 2b Study in NASH to Assess IVA337

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Inventiva Pharma 247
Large-scale testing (Phase 3)Study completedNCT01051219
What this trial is testing

Anti-Fibrotic Effects of Losartan In Nash Evaluation Study

Who this might be right for
Nonalcoholic Steatohepatitis
Newcastle-upon-Tyne Hospitals NHS Trust 45
Testing effectiveness (Phase 2)Study completedNCT02653300
What this trial is testing

A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)Type2 Diabetes Mellitus
Oramed, Ltd. 10
Not applicableWithdrawnNCT05050721
What this trial is testing

Natural History of Non Alcoholic Fatty Liver Disease and Predictors of Advanced Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis (NASH)
Methodist Health System
Not applicableUnknownNCT03377153
What this trial is testing

The Effects of Hesperidin and Flaxseed on Biochemical Factors and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 50
Testing effectiveness (Phase 2)Study completedNCT02776059
What this trial is testing

Pegfilgrastim in Patients With Alcoholic Hepatitis

Who this might be right for
Alcoholic Hepatitis
Timothy Morgan, MD 34
Testing effectiveness (Phase 2)Looking for participantsNCT04250259
What this trial is testing

SAMe Trial for Patients With Alcoholic Cirrhosis

Who this might be right for
Alcoholic Cirrhosis
Indiana University 196
Not applicableWithdrawnNCT01987310
What this trial is testing

Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment

Who this might be right for
Non Alcoholic Fatty Liver Disease
Sheba Medical Center
Next Page